Health Care Research and Customer Insights

Our Objective Insights. Your Strategic Advantage.

Darwin Research Group delivers strategic intelligence and deep executive insights that guide health care leaders to make confident decisions. Our expert knowledge of the ever-evolving health care landscape gives you the perspective you need to stay ahead.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Darwin's Our Take 6.22.26: Study finds general-purpose LLMs perform better than specialized clinical AI tools

adventhealth

June 22, 2026

Darwin's Our Take 6.22.26: Study finds general-purpose LLMs perform better than specialized clinical AI tools

Darwin's Our Take 6.15.26: GSK grows lung cancer portfolio with $10.6 billion Nuvalent acquisition

gsk

j&j

June 15, 2026

Darwin's Our Take 6.15.26: GSK grows lung cancer portfolio with $10.6 billion Nuvalent acquisition

Darwin's Our Take 6.8.26: Feature: Health systems gain AI governance controls as collaborations proliferate

cleveland clinic

hospital

June 8, 2026

Darwin's Our Take 6.8.26: Feature: Health systems gain AI governance controls as collaborations proliferate

Providing insights for the most prominent leaders in health care.

Our Services

We’re here to serve you.

We provide the intelligence and insight health care leaders need to move beyond transactions and build a more connected, strategic approach to growth.

Explore all Services

Consulting & Strategic Counsel

We work with CEOs and other senior executives and tailor strategic intelligence services to the specific needs of the highest levels in an organization. Darwin CEO John Marchica leads this effort, providing his analysis and guidance directly to the client.

Learn More

Customer Intelligence, Data, & Profiles

We develop each health system profile profile with rigor and strategic intent, and complete it with rich, actionable insights across all facets of the organization.

Learn More

Inside Access To Research & Data

When our clients need to sharpen their business, marketing, market access, and sales strategies, they rely on the customer profiles we develop to inform and enhance their decision making, using them over and over again as a vital “go to” resource.

Learn More

Are you getting the right information you need to make decisions?

Featured Insights from Darwin

Our Take Newsletter

Darwin's Our Take 6.22.26: Study finds general-purpose LLMs perform better than specialized clinical AI tools

Learn More

Our Take Newsletter

Darwin's Our Take 6.15.26: GSK grows lung cancer portfolio with $10.6 billion Nuvalent acquisition

Learn More

Our Take Newsletter

Darwin's Our Take 6.8.26: Feature: Health systems gain AI governance controls as collaborations proliferate

Learn More

podcast

June 26, 2026

Podcast 209: Inside the Rural Health Transformation Program w/ Dr. Tim Ferris, InterSystems

Listen in

podcast

June 12, 2026

Podcast 208: The Affordability Crisis Behind Value-Based Care w/ Dr. Michael Chernew, Harvard

Listen in

podcast

May 29, 2026

Podcast 207: What’s Holding Back Value-Based Care? w/ Don Calcagno, Founder, ValuesEdge

Listen in

podcast

May 15, 2026

Podcast 206: Why Membership Medicine Could Save Primary Care w/ Larry Kutscher, CEO, MDVIP

Listen in

podcast

May 1, 2026

Podcast 205: Why Health Care Treats Instead of Prevents w/ Dr. Barry R. Davis, Author, The Preventioneers

Listen in

Explore All Content

Stay Aware. Stay Informed.

Subscribe to Our Take

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Explore Content

Our Objective Insights. Your Strategic Advantage.

Darwin Research Group delivers strategic intelligence and deep executive insights that guide health care leaders to make confident decisions. Our expert knowledge of the ever-evolving health care landscape gives you the perspective you need to stay ahead.

Darwin's Our Take 6.22.26: Study finds general-purpose LLMs perform better than specialized clinical AI tools

Darwin's Our Take 6.15.26: GSK grows lung cancer portfolio with $10.6 billion Nuvalent acquisition

Darwin's Our Take 6.8.26: Feature: Health systems gain AI governance controls as collaborations proliferate

Providing insights for the most prominent leaders in health care.

We’re here to serve you.

Consulting & Strategic Counsel

Customer Intelligence, Data, & Profiles

Inside Access To Research & Data

Are you getting the right information you need to make decisions?

Featured Insights from Darwin

Darwin's Our Take 6.22.26: Study finds general-purpose LLMs perform better than specialized clinical AI tools

Darwin's Our Take 6.15.26: GSK grows lung cancer portfolio with $10.6 billion Nuvalent acquisition

Darwin's Our Take 6.8.26: Feature: Health systems gain AI governance controls as collaborations proliferate

Podcast 209: Inside the Rural Health Transformation Program w/ Dr. Tim Ferris, InterSystems

Podcast 208: The Affordability Crisis Behind Value-Based Care w/ Dr. Michael Chernew, Harvard

Podcast 207: What’s Holding Back Value-Based Care? w/ Don Calcagno, Founder, ValuesEdge

Podcast 206: Why Membership Medicine Could Save Primary Care w/ Larry Kutscher, CEO, MDVIP

Podcast 205: Why Health Care Treats Instead of Prevents w/ Dr. Barry R. Davis, Author, The Preventioneers

Subscribe to Our Take

Podcast 209: Inside the Rural Health Transformation Program w/ Dr. Tim Ferris, InterSystems

Podcast 208: The Affordability Crisis Behind Value-Based Care w/ Dr. Michael Chernew, Harvard

Podcast 207: What’s Holding Back Value-Based Care? w/ Don Calcagno, Founder, ValuesEdge

Services

Company